This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Society of NeuroInterventional Surgery | |
|---|---|
| Name | Society of NeuroInterventional Surgery |
| Abbreviation | SNIS |
| Formation | 1992 |
| Headquarters | United States |
| Leader title | President |
Society of NeuroInterventional Surgery is a professional medical association focusing on minimally invasive treatment of cerebrovascular disease and neurovascular disorders. Founded in 1992, the society connects physicians and allied professionals involved in endovascular neurosurgery, interventional neuroradiology, and endovascular neurology, and collaborates with hospitals, regulatory agencies, and international societies to advance patient care. The society organizes annual meetings, issues clinical guidance, supports registries, and advocates before agencies and legislatures for policies affecting cerebrovascular intervention.
The society emerged in the early 1990s amid rapid advances in endovascular technology, influenced by pioneers associated with institutions such as Massachusetts General Hospital, Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, and UCLA Medical Center, and by collaborative networks that included members of American Medical Association, American Heart Association, World Federation of Interventional and Therapeutic Neuroradiology, European Society of Minimally Invasive Neurological Therapy, and American College of Surgeons. Early formative meetings involved leaders linked to University of California, San Francisco, Columbia University Irving Medical Center, Mount Sinai Health System, Stanford University Medical Center, and University of Pennsylvania Health System. Growth tracked device approvals by Food and Drug Administration and reimbursement policies debated before Centers for Medicare & Medicaid Services and legislative bodies in United States Congress, with cross-disciplinary engagement from representatives of Neurosurgery Research and Education Foundation, Radiological Society of North America, American Academy of Neurology, and specialty groups in Canada, United Kingdom, Germany, and Japan.
The organization’s mission aligns with objectives to improve care for patients with stroke, aneurysm, and vascular malformations through collaboration with institutions such as World Health Organization, European Stroke Organisation, American Stroke Association, National Institutes of Health, and Agency for Healthcare Research and Quality. It promotes evidence-based practice consistent with standards developed by entities like Institute of Medicine, Joint Commission, and ISO committees, and fosters partnerships with payer organizations including Blue Cross Blue Shield plans and professional societies such as American Association of Neurological Surgeons and Congress of Neurological Surgeons to enhance access to neurointerventional therapies.
Membership encompasses physicians trained in endovascular neurosurgery, interventional neuroradiology, and endovascular neurology from centers such as Barnes-Jewish Hospital, St. Jude Children’s Research Hospital, Royal London Hospital, Karolinska University Hospital, and Toronto General Hospital, along with allied health professionals and trainees from programs at Harvard Medical School, Yale School of Medicine, Icahn School of Medicine at Mount Sinai, and University of Michigan Medical School. Governance typically features an elected board, committees, and task forces that interface with accreditation bodies like Accreditation Council for Graduate Medical Education and certification boards including American Board of Neurological Surgery, American Board of Radiology, and American Board of Psychiatry and Neurology.
The society issues clinical practice guidelines and position statements addressing management of acute ischemic stroke, intracranial aneurysm, carotid disease, and arteriovenous malformations, aligning recommendations with randomized trials conducted at centers such as ESCAPE investigators, MR CLEAN trial investigators, DAWN study sites, DEFUSE 3 investigators, and device trials involving manufacturers regulated by the Food and Drug Administration. Position statements engage with regulatory frameworks of European Medicines Agency, reimbursement policies of Centers for Medicare & Medicaid Services, and standards of organizations including World Federation of Neurological Societies and Society for Vascular Surgery.
The society sponsors education through annual meetings, workshops, fellowship directories, and hands-on simulation courses in collaboration with academic centers like University of Toronto, University College London Hospitals, Karolinska Institutet, and National University of Singapore. Training initiatives coordinate with accreditation organizations such as Accreditation Council for Graduate Medical Education and certification entities including American Board of Neurological Surgery, and interact with continuing medical education providers accredited by Accreditation Council for Continuing Medical Education. Fellowship programs often trace lineage to training sites at Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, Toronto Western Hospital, and other major referral centers.
The society supports multicenter research and national registries for endovascular procedures, contributing data comparable to registries maintained by Get With The Guidelines–Stroke, National Inpatient Sample, SVS Vascular Quality Initiative, and collaborates with funding agencies such as National Institutes of Health, Wellcome Trust, European Research Council, and philanthropic foundations like Bill & Melinda Gates Foundation on global projects. Its members publish in journals including Journal of NeuroInterventional Surgery, Stroke, Neurosurgery, AJNR American Journal of Neuroradiology, and The Lancet and present findings at meetings of European Stroke Organisation Conference, International Stroke Conference, and American Heart Association Scientific Sessions.
Advocacy efforts target policymakers in United States Congress, regulators at Food and Drug Administration, payers such as Centers for Medicare & Medicaid Services, and public health agencies like Centers for Disease Control and Prevention to shape stroke systems of care, workforce policies, and device regulation. Public outreach includes stroke awareness campaigns coordinated with organizations like American Heart Association, National Stroke Association, World Stroke Organization, and patient advocacy groups at institutions such as National Institutes of Health centers and regional stroke advocacy coalitions.
Category:Medical associations Category:Neurosurgery Category:Neurology